Bluebird Botanicals

Business news, market intelligence, and global industry analysis.

The Latest

Can fewer infusions improve adherence in Fabry disease enzyme replacement therapy?

CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m

What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)

CVGI surges 54% as CVG names Zoox strategic supplier and issues $700M revenue outlook for 2026

Representative image of CBD oils, capsules, and creams reflecting the strategic integration of Bluebird Botanicals into cbdMD’s wellness portfolio and cannabinoid product ecosystem.

Can Bluebird Botanicals help cbdMD reclaim leadership in the evolving wellness market?

cbdMD acquires Bluebird Botanicals to expand IP, unify brands, and boost 2026 profitability. Find out how this move reshapes the cannabinoid wellness market.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

January 15, 2026